Abstract
Inhibitors of phosphodiesterase type 5 (PDE-5) are well established as an oral treatment for the majority of patients with erectile dysfunction (ED). PDE-5 is found in high concentration in smooth muscle cells of the corpora cavernosa. However, enzymes of the PDE family are also expressed in various other tissues, including the brain. Little is known about its effects on the central nervous system (CNS), although it has been suggested that PDE-5 inhibitors might cross the blood–brain barrier. Side effects, such as headache, nasal congestion, flushing, nausea, are much more common. We describe a patient who had a transient global amnesia (TGA) after his first-ever use of tadalafil, a potent PDE-5 inhibitor. Despite the fact that the aetiology of TGA has not entirely been clarified at present, we consider the hypothesis of a causal relationship as tempting with respect to the current hypotheses of TGA pathophysiology. This case, together with others, suggests that PDE-5 inhibitors might be capable of exerting adverse effects in the CNS. Physicians should be aware of the possibility of neurological disturbances when prescribing PDE-5 inhibitors for ED.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Carson CC et al. The efficacy and safety of tadalafil: an update. BJU Int 2004; 93: 1276–1281.
Morgan JC, Alhatou M, Oberlies J, Johnston KC . Transient ischemic attack and stroke associated with sildenafil (Viagra) use. Neurology 2001; 57: 1730–1731.
Monastero R, Pipia C, Camarda LK, Camarda R . Intracerebral haemorrhage associated with sildenafil citrate. J Neurol 2001; 248: 141–142.
Buxton N, Fannery T, Wild D . Sildenafil (Viagra)-induced spontaneous intracerebral haemorrhage. Br J Neurosurg 2001; 15: 347–349.
Gilad R, Lampl Y, Eshel Y, Sadeh M . Tonic–clonic seizures in patients taking sildenafil. BMJ 2002; 325: 869.
Gandolfo C, Sugo A, Del Sette M . Sildenafil and transient global amnesia. Neurol Sci 2003; 24: 145–146.
Savitz SA, Caplan LR . Transient global amnesia after sildenafil (Viagra) use. Neurology 2002; 59: 778.
Hodges JR, Warlow CP . Syndromes of transient amnesia: towards a classification. A study of 153 cases. J Neurol Neurosurg Psychiatry 1990; 53: 834–843.
Lauria G et al. Incidence of transient global amnesia in the Belluno province, Italy: 1985 through 1995. Results of a community-based study. Acta Neurol Scand 1997; 95: 303–310.
Milman HA, Arnold SB . Neurologic, psychological, and aggressive disturbances with sildenafil. Ann Pharmacother 2002; 36: 1129–1134.
Loughney K et al. Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3′,5′-cyclic nucleotide phosphodiesterase. Gene 1998; 216: 139–147.
Schultheiss D et al. Central effects of sildenafil (Viagra) on auditory selective attention and verbal recognition memory in humans: a study with event-related brain potentials. World J Urol 2001; 19: 46–50.
Lewis SL . Aetiology of transient global amnesia. Lancet 1998; 352: 397–399.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schiefer, J., Sparing, R. Transient global amnesia after intake of tadalafil, a PDE-5 inhibitor: a possible association?. Int J Impot Res 17, 383–384 (2005). https://doi.org/10.1038/sj.ijir.3901301
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijir.3901301